OWC

OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary One World Cannabis Ltd. (collectively referred to as "OWC" or "the Company"), conducts medical research and clinical trials to develop cannabis-based drugs and treatments for multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines.OWCP has also developed unique delivery systems for the effective administration and use of medical cannabis. All of OWCP's research is conducted at leading hospitals and research institutions in Israel and is led by internationally renowned researchers. The company’s research division focuses on conducting clinical trials to evaluate the efficacy of cannabinoids and cannabis-based products in treating various conditions, while its consulting division is dedicated to assisting governments and companies in navigating the complex international cannabis regulatory framework.